A method for producing epothilone b

A technology for epothilone and bacteria production, which is applied in the directions of microorganism-based methods, biochemical equipment and methods, microorganisms, etc., can solve the problems such as the inability to meet the needs of large-scale production, and achieves the advantages of subsequent extraction and purification, easy promotion, and industrialization. low cost effect
CN106834377BActive Publication Date: 2020-05-05LUNAN BETTER PHARMA

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
LUNAN BETTER PHARMA
Publication Date
2020-05-05
Patent Text Reader

Abstract

The invention concretely discloses a fermentation method for producing epothilone B, and belongs to the field of biological fermentation. According to the method, during culturing of a seeding tank, ammonia hydroxide is added in a flowing mode to adjust the pH value, so that a lot of seed thalli are obtained; during fermentation, ammonia hydroxide or propanoic acid is added in a flowing mode to regulate the pH value, in this way, the yield of the epothilone B is increased, the regulation procedures are simplified, production cost is lowered, industrialized production is easy, and application prospects are good.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention belongs to the field of biological fermentation, and in particular relates to a method for producing epothilone B. Background technique

[0002] Epothilones (epothilones) was discovered in 1993 in the secondary metabolites of the myxobacteria Sorangium cellulosum, and its structure is a macrolide compound. The anti-tumor mechanism is similar to that of paclitaxel, which has the effect of inhibiting microtubule depolymerization. In contrast, epothilone is more water-soluble and has a strong effect on both multidrug-resistant tumor cells and paclitaxel-resistant tumor cells. It has anticancer activity and does not have serious side effects such as granulocytopenia, peripheral neuropathy, alopecia, and allergy in the clinical application of paclitaxel. Therefore, the development of epothilones has clinical value and social significance. In 2007, ixabepilone, a derivative of epothilones B, was approved for marketing in the United States, wh...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More